A | SK | SECTION A — HUMAN NECESSITIES |
A61 | USK | HEALTH; AMUSEMENT |
A61 | KL | MEDICAL OR VETERINARY SCIENCE; HYGIENE |
A61L | UKL | METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agent employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toilet purposes A61K; preparation of ozone C01B 13/10) [4] |
|
A61L 2/00 | HGR | Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor (for contact lenses A61L 12/00; atomisers for disinfecting agents A61M; sterilisation of packages or package contents in association with packaging B65B 55/00; treatment of water, waste water, sewage or sludge C02F; disinfecting paper D21H 21/36; disinfecting devices for water closets E03D; articles having provision for disinfection, see the relevant subclasses for these articles, e.g. H04R 1/12) [3, 5, 7] |
A61L 2/02 | UGR1 | . | using physical phenomena [3] |
|
A61L 2/025 | UGR2 | |
A61L 2/03 | UGR2 | . . | Electric current, e.g. electrolysis [7] |
|
A61L 2/04 | UGR2 | |
A61L 2/06 | UGR3 | |
A61L 2/07 | UGR4 | |
A61L 2/08 | UGR2 | |
A61L 2/10 | UGR3 | . . . | Ultra-violet radiation [3] |
|
A61L 2/12 | UGR3 | |
A61L 2/14 | UGR2 | . . | Plasma, i.e. ionised gases [3] |
|
A61L 2/16 | UGR1 | . | using chemical substances [3] |
|
A61L 2/18 | UGR2 | |
A61L 2/20 | UGR2 | . . | Gaseous substances, e.g. vapours [3] |
|
A61L 2/22 | UGR2 | . . | Phase substances, e.g. smokes, aerosols [3] |
|
A61L 2/23 | UGR2 | . . | Solid substances, e.g. granules, powders, blocks, tablets [7] |
|
A61L 2/232 | UGR3 | . . . | layered or coated [7] |
|
A61L 2/235 | UGR3 | . . . | cellular, porous or foamed [7] |
|
A61L 2/238 | UGR3 | . . . | Metals or alloys, e.g. oligodynamic metals [7] |
|
A61L 2/24 | UGR1 | . | Apparatus using programmed or automatic operation [3] |
|
A61L 2/26 | UGR1 | |
A61L 2/28 | UGR2 | . . | Devices for testing the effectiveness or completeness of sterilisation, e.g. indicators which change colour (methods involving enzymes or micro-organisms C12Q 1/00; apparatus involving enzymes or micro-organisms C12M 1/34) [7] |
|
A61L 9/00 | HGR | Disinfection, sterilisation or deodorisation of air (body deodorants A61K 8/00, A61Q 15/00; purifying air by respirators A62B, A62D 9/00; separating dispersed particles from gases or vapours B01D 45/00-B01D 51/00, B03C 3/00; chemical or biological purification of waste gases B01D 53/34; production of ozone C01B 13/10; air-conditioning systems incorporating sterilisation F24F 3/16) |
A61L 9/01 | UGR1 | . | Deodorant compositions [2] |
|
A61L 9/012 | UGR2 | . . | characterised by being in a special form, e.g. gels, emulsions [7] |
|
A61L 9/013 | UGR2 | . . | containing animal or plant extracts, or vegetable material [7] |
|
A61L 9/014 | UGR2 | . . | containing sorbent material, e.g. activated carbon [7] |
|
A61L 9/015 | UGR1 | . | using gaseous or vaporous substances, e.g. ozone (A61L 9/20 takes precedence) [3] |
|
A61L 9/02 | UGR2 | . . | using substances evaporated in the air by heating or combustion [3] |
|
A61L 9/03 | UGR3 | . . . | Apparatus therefor [3] |
|
A61L 9/04 | UGR2 | . . | using substances evaporated in the air without heating [3] |
|
A61L 9/05 | UGR3 | . . . | specially adapted to be released by contact with a liquid, e.g. for toilets [7] |
|
A61L 9/12 | UGR3 | . . . | Apparatus, e.g. holders, therefor [3] |
|
A61L 9/14 | UGR1 | . | using sprayed or atomised substances [3] |
|
A61L 9/16 | UGR1 | . | using physical phenomena [3] |
|
A61L 9/18 | UGR2 | . . | Radiation (A61L 9/22 takes precedence) [3] |
|
A61L 9/20 | UGR3 | . . . | Ultra-violet radiation [3] |
|
A61L 9/22 | UGR2 | |
A61L 11/00 | HGR | Methods specially adapted for refuse |
A61L 12/00 | HGR | Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor [7] |
A61L 12/02 | UGR1 | . | using physical phenomena, e.g. electricity, ultrasonics or ultrafiltration [7] |
|
A61L 12/04 | UGR2 | |
A61L 12/06 | UGR2 | . . | Radiation, e.g. ultra-violet or microwaves [7] |
|
A61L 12/08 | UGR1 | . | using chemical substances [7] |
|
A61L 12/10 | UGR2 | . . | Halogens or compounds thereof [7] |
|
A61L 12/12 | UGR2 | . . | Non-macromolecular oxygen-containing compounds, e.g hydrogen peroxide or ozone (A61L 12/10 takes precedence) [7] |
|
A61L 12/14 | UGR2 | |
|
A61L 15/00 | HGR | Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads (for liquid bandages A61L 26/00; radioactive dressings A61M 36/14) |
A61L 15/07 | UGR1 | |
A61L 15/08 | UGR2 | . . | containing inorganic materials, e.g. plaster of Paris [5] |
|
A61L 15/10 | UGR2 | . . | containing organic materials [5] |
|
A61L 15/12 | UGR2 | . . | containing macromolecular materials [5] |
|
A61L 15/14 | UGR2 | . . | Use of materials characterised by their function or physical properties [5] |
|
A61L 15/16 | UGR1 | . | Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons [5] |
|
A61L 15/18 | UGR2 | . . | containing inorganic materials [5] |
|
A61L 15/20 | UGR2 | . . | containing organic materials [5] |
|
A61L 15/22 | UGR2 | . . | containing macromolecular materials [5] |
|
A61L 15/24 | UGR3 | . . . | Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof [5] |
|
A61L 15/26 | UGR3 | . . . | Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof [5] |
|
A61L 15/28 | UGR3 | . . . | Polysaccharides or their derivatives [5] |
|
A61L 15/30 | UGR3 | . . . | Rubbers or their derivatives [5] |
|
A61L 15/32 | UGR3 | . . . | Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin [5] |
|
A61L 15/34 | UGR3 | . . . | Oils, fats, waxes, or natural resins [5] |
|
A61L 15/36 | UGR2 | . . | containing micro-organisms [5] |
|
A61L 15/38 | UGR2 | . . | containing enzymes [5] |
|
A61L 15/40 | UGR2 | . . | containing ingredients of undetermined constitution or reaction products thereof [5] |
|
A61L 15/42 | UGR2 | . . | Use of materials characterised by their function or physical properties [5] |
|
A61L 15/44 | UGR3 | |
A61L 15/46 | UGR3 | . . . | Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria [5] |
|
A61L 15/48 | UGR3 | |
A61L 15/50 | UGR3 | . . . | Lubricants; Anti-adhesive agents [5] |
|
A61L 15/52 | UGR3 | . . . | Water-repellants [5] |
|
A61L 15/54 | UGR3 | . . . | Radio-opaque materials [5] |
|
A61L 15/56 | UGR3 | . . . | Wetness-indicators or colorants [5] |
|
A61L 15/58 | UGR3 | . . . | Adhesives (electrically conductive adhesives for use in therapy or testing in vivoA61K 50/00) [5] |
|
A61L 15/60 | UGR3 | . . . | Liquid-swellable gel-forming materials, e.g. super-absorbents [5] |
|
A61L 15/62 | UGR3 | . . . | Hydrosoluble or hydrodegradable materials [5] |
|
A61L 15/64 | UGR3 | . . . | specially adapted to be resorbable inside the body [5] |
|
A61L 17/00 | HGR | Materials for surgical sutures or for ligaturing blood vessels (surgical adhesives A61L 24/00; surgical instruments, devices or methods for suturing or ligaturing A61B 17/04, A61B 17/12; supports or packages for suture materials A61B 17/04) [3, 4] |
A61L 17/04 | UGR1 | . | Non-resorbable materials [7] |
|
A61L 17/06 | UGR1 | . | At least partly resorbable materials [7] |
|
A61L 17/08 | UGR2 | . . | of animal origin, e.g. catgut, collagen [7] |
|
A61L 17/10 | UGR2 | . . | containing macromolecular materials [7] |
|
A61L 17/12 | UGR3 | . . . | Homopolymers or copolymers of glycolic or lactic acid [7] |
|
A61L 17/14 | UGR1 | . | Post-treatment to improve physical properties [7] |
|
A61L 24/00 | HGR | Surgical adhesives or cements; Adhesives for colostomy devices (electrically conductive adhesives for use in therapy or testing in vivoA61K 50/00) [7] |
A61L 24/02 | UGR1 | . | containing inorganic materials [7] |
|
A61L 24/04 | UGR1 | . | containing macromolecular materials [7] |
|
A61L 24/06 | UGR2 | . . | obtained by reactions only involving carbon-to-carbon unsaturated bonds [7] |
|
A61L 24/08 | UGR2 | |
A61L 24/10 | UGR2 | . . | Polypeptides; Proteins [7] |
|
A61L 24/12 | UGR2 | . . | Ionomer cements, e.g. glass-ionomer cements [7] |
|
A61L 26/00 | HGR | Chemical aspects of, or use of materials for, liquid bandages [7] |
A61L 27/00 | HGR | Materials for prostheses or for coating prostheses (dental prostheses A61C 13/00; shape or structure of prostheses A61F 2/00; use of preparations for artificial teeth A61K 6/02; artificial kidneys A61M 1/14) [4] |
A61L 27/02 | UGR1 | |
A61L 27/04 | UGR2 | |
A61L 27/06 | UGR3 | . . . | Titanium or titanium alloys [7] |
|
A61L 27/08 | UGR2 | |
A61L 27/10 | UGR2 | . . | Ceramics or glasses [7] |
|
A61L 27/12 | UGR2 | . . | Phosphorus-containing materials, e.g. apatite [7] |
|
A61L 27/14 | UGR1 | . | Macromolecular materials [7] |
|
A61L 27/16 | UGR2 | . . | obtained by reactions only involving carbon-to-carbon unsaturated bonds [7] |
|
A61L 27/18 | UGR2 | . . | obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [7] |
|
A61L 27/20 | UGR2 | |
A61L 27/22 | UGR2 | . . | Polypeptides or derivatives thereof [7] |
|
A61L 27/24 | UGR3 | |
A61L 27/26 | UGR2 | . . | Mixtures of macromolecular materials [7] |
|
A61L 27/28 | UGR1 | . | Materials for coating prostheses [7] |
|
A61L 27/30 | UGR2 | . . | Inorganic materials [7] |
|
A61L 27/32 | UGR3 | . . . | Phosphorus-containing materials, e.g. apatite [7] |
|
A61L 27/34 | UGR2 | . . | Macromolecular materials [7] |
|
A61L 27/36 | UGR1 | . | containing ingredients of undetermined constitution or reaction products thereof [7] |
|
A61L 27/38 | UGR2 | . . | Animal cells (for use in artificial skin A61L 27/60) [7] |
|
A61L 27/40 | UGR1 | . | Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material [7] |
|
A61L 27/42 | UGR2 | . . | having an inorganic matrix [7] |
|
A61L 27/44 | UGR2 | . . | having a macromolecular matrix [7] |
|
A61L 27/46 | UGR3 | . . . | with phosphorus-containing inorganic fillers [7] |
|
A61L 27/48 | UGR3 | . . . | with macromolecular fillers [7] |
|
A61L 27/50 | UGR1 | . | Materials characterised by their function or physical properties [7] |
|
A61L 27/52 | UGR2 | . . | Hydrogels or hydrocolloids [7] |
|
A61L 27/54 | UGR2 | . . | Biologically active materials, e.g. therapeutic substances [7] |
|
A61L 27/56 | UGR2 | . . | Porous or cellular materials [7] |
|
A61L 27/58 | UGR2 | . . | Materials at least partially resorbable by the body [7] |
|
A61L 27/60 | UGR2 | . . | Materials for use in artificial skin [7] |
|
A61L 28/00 | HGR | Materials for colostomy devices (adhesives for colostomy devices A61L 24/00) [7] |
A61L 29/00 | HGR | Materials for catheters or for coating catheters (shape or structure of catheters A61M 25/00) [4] |
A61L 29/02 | UGR1 | |
A61L 29/04 | UGR1 | . | Macromolecular materials [7] |
|
A61L 29/06 | UGR2 | . . | obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [7] |
|
A61L 29/08 | UGR1 | . | Materials for coatings [7] |
|
A61L 29/10 | UGR2 | . . | Inorganic materials [7] |
|
A61L 29/12 | UGR1 | . | Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material [7] |
|
A61L 29/14 | UGR1 | . | Materials characterised by their function or physical properties [7] |
|
A61L 29/16 | UGR2 | . . | Biologically active materials, e.g. therapeutic substances [7] |
|
A61L 29/18 | UGR2 | . . | Materials at least partially X-ray or laser opaque [7] |
|
A61L 31/00 | HGR | Materials for other surgical articles [4] |
A61L 31/02 | UGR1 | |
A61L 31/04 | UGR1 | . | Macromolecular materials [7] |
|
A61L 31/06 | UGR2 | . . | obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [7] |
|
A61L 31/08 | UGR1 | . | Materials for coatings [7] |
|
A61L 31/10 | UGR2 | . . | Macromolecular materials [7] |
|
A61L 31/12 | UGR1 | . | Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material [7] |
|
A61L 31/14 | UGR1 | . | Materials characterised by their function or physical properties [7] |
|
A61L 31/16 | UGR2 | . . | Biologically active materials, e.g. therapeutic substances [7] |
|
A61L 31/18 | UGR2 | . . | Materials at least partially X-ray or laser opaque [7] |
|
A61L 33/00 | HGR | Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment [4, 7] |
A61L 33/02 | UGR1 | . | Use of inorganic materials [7] |
|
A61L 33/04 | UGR1 | . | Use of organic materials, e.g. acetylsalicylic acid [7] |
|
A61L 33/06 | UGR1 | . | Use of macromolecular materials [7] |
|
A61L 33/08 | UGR2 | |
A61L 33/10 | UGR3 | . . . | Heparin, heparinoid or derivatives thereof [7] |
|
A61L 33/12 | UGR2 | . . | Polypeptides, proteins or derivatives thereof [7] |
|
A61L 33/14 | UGR1 | . | Use of fibrinolytic agents or platelet aggregation inhibitors [7] |
|
A61L 33/16 | UGR1 | . | Use of enzymes, e.g. urokinase, streptokinase [7] |
|
A61L 33/18 | UGR1 | . | Use of ingredients of undertermined constitution or reaction products thereof [7] |
|
|
A61L 101/00 | HGR | Chemical composition of materials used in disinfecting, sterilising or deodorising [7] |
A61L 101/02 | UGR1 | |
A61L 101/04 | UGR2 | . . | Elemental carbon, e.g. active charcoal [7] |
|
A61L 101/06 | UGR2 | . . | containing halogen [7] |
|
A61L 101/08 | UGR3 | . . . | Elemental halogen [7] |
|
A61L 101/10 | UGR2 | |
A61L 101/12 | UGR2 | . . | containing silicon [7] |
|
A61L 101/14 | UGR2 | |
A61L 101/16 | UGR2 | . . | containing phosphorus [7] |
|
A61L 101/18 | UGR2 | |
A61L 101/20 | UGR2 | |
A61L 101/22 | UGR2 | |
A61L 101/24 | UGR2 | . . | containing aluminium [7] |
|
A61L 101/26 | UGR2 | |
A61L 101/28 | UGR2 | |
A61L 101/30 | UGR2 | |
A61L 101/32 | UGR1 | |
A61L 101/34 | UGR2 | |
A61L 101/36 | UGR2 | . . | Carboxylic acids or derivatives thereof [7] |
|
A61L 101/38 | UGR2 | |
A61L 101/40 | UGR2 | |
A61L 101/42 | UGR2 | . . | Organo-metallic compounds or complexes [7] |
|
A61L 101/44 | UGR2 | . . | Heterocyclic compounds [7] |
|
A61L 101/46 | UGR2 | . . | Macromolecular compounds [7] |
|
A61L 101/48 | UGR3 | . . . | obtained by reactions only involving carbon-to-carbon unsaturated bonds [7] |
|
A61L 101/50 | UGR3 | . . . | Polysaccharides or derivatives thereof [7] |
|
A61L 101/52 | UGR1 | . | Micro-organisms or substances produced by or extracted from micro-organisms [7] |
|
A61L 101/54 | UGR1 | |
A61L 101/56 | UGR1 | . | Plant extracts or vegetable products of undetermined chemical constitution, e.g. plant fibre [7] |
|